Who is sponsoring NCT06263192?

NCT06263192 is sponsored by Jose Antonio Moreno.

What drugs are being tested in NCT06263192?

Interventions in NCT06263192: Intrauterine insemination.

What condition does NCT06263192 study?

NCT06263192 studies Infertility, Female, Anti-Mullerian Hormone Deficiency.

Is NCT06263192 still recruiting?

NCT06263192 is currently completed. Last updated 16 February 2024.

Last reviewed 2024-02-16 · How we verify

NCT06263192

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pregnancy Prediction Using Anti-Müllerian Hormone in Intrauterine Insemination Cycles

Completed Last updated 16 February 2024

What this trial tests

trial testing Intrauterine insemination in Infertility, Female in 342 participants. Completed in 1 May 2023.

Timeline

1 October 2020

Primary endpoint
1 December 2022

1 May 2023

Quick facts

Lead sponsor	Jose Antonio Moreno
Status	Completed
Study type	OBSERVATIONAL
Enrollment	342
Start date	1 October 2020
Primary completion	1 December 2022
Estimated completion	1 May 2023
Sites	1 location across Spain

Drugs / interventions tested

Intrauterine insemination

Conditions studied

Infertility, Female — all drugs for Infertility, Female →
Anti-Mullerian Hormone Deficiency — all drugs for Anti-Mullerian Hormone Deficiency →

Sponsor

Jose Antonio Moreno

Who can join

Adults 25 to 39, female only, with Infertility, Female or Anti-Mullerian Hormone Deficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to compare the cumulative pregnancy rates after 4 artificial inseminations with donor (IAD) in non-sterile women with plasma AMH levels \> and \< 1.1 ng/mL.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Anti-Müllerian hormone does not predict cumulative pregnancy rate in non-infertile women following four IUI cycles with donor sperm.
Gayete-Lafuente S, Moreno-Sepulveda J, Sánchez-Álvarez J, Prat M, et al · · 2024 · PMID 38987421 · DOI 10.1007/s10815-024-03188-5

Verify or expand the search:

Other trials of Intrauterine insemination

Trials testing the same drug.

NCT05999591 — Total Motile Sperm Count and Pregnancy Rate From Intrauterine Insemination · completed

Other recruiting trials for Infertility, Female

Currently open trials in the same condition.

NCT06771401 — Identification of Biomarkers in Cervical Mucus · NA · recruiting
NCT06984081 — CAPA In-vitro Oocyte Maturation · NA · recruiting
NCT07308561 — The Relationship Between Quality of Life, Anxiety Levels, and Attitudes Toward Artificial Intelligence Among Women Under · recruiting
NCT07175571 — SISTER: Sibling Oocyte Insemination With Frozen Sperm From Third Party Donors: Evaluation of Reproductive Techniques · NA · recruiting
NCT06193135 — Usefulness of Corifollitropin α as Alternative to Conventional Daily rFSH Protocols in Oocyte Donors Undergoing Pituitar · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06263192 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Jose Antonio Moreno
Last refreshed: 16 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06263192.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing